Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen

M Kolpen1, T Bjarnsholt, C Moser

  • 1Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark; Department of International Health, Immunology and Microbiology, Faculty of Health Sciences, University of Copenhagen, Helsingør, Denmark.

Insights

Polymorphonuclear leukocytes (PMNs) in cystic fibrosis (CF) lung infections consume oxygen not only for superoxide production but also for nitric oxide (NO) generation. This finding reveals a dual role for PMNs in CF airway inflammation.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Microbiology

Background:

  • Chronic Pseudomonas aeruginosa infection in cystic fibrosis (CF) patients involves mucoid biofilms in hypoxic mucus.
  • These biofilms are associated with polymorphonuclear leukocytes (PMNs) that consume oxygen (O(2)) to produce superoxide (O(2)(-)).

Purpose of the Study:

  • To investigate whether PMNs in CF sputum also consume O(2) for nitric oxide (NO) production.
  • To quantify and visualize NO production in CF sputum and its correlation with PMN concentration.

Main Methods:

  • Analysis of sputum samples from CF patients using optode measurements, fluorescence microscopy, flow cytometry, and spectrophotometry.
  • Quantification of NO production and its inhibition using nitric oxide synthases (NOS) inhibitor N(G)-monomethyl-L-arginine (L-NMMA).
  • Identification of PMNs and host cells expressing inducible NOS (iNOS) using specific fluorescent indicators.

Main Results:

  • PMNs in CF sputum consume O(2) for NO production via NOS.
  • Inhibition of NOS reduced O(2) consumption and NO production.
  • NO production correlated positively with PMN concentration in CF sputum.

Conclusions:

  • PMNs in CF sputum contribute to airway inflammation through both superoxide and NO production.
  • This dual oxygen consumption by PMNs has implications for the understanding and treatment of CF lung infections.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
657
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.3K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K